| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/16/2000 | CN1244536A Angiogenesis inhibiting factor 1 and its derivative and application |
| 02/16/2000 | CN1049454C Method for producing transgenic corn plants |
| 02/15/2000 | US6025546 Method to obtain male sterile plants |
| 02/15/2000 | US6025542 Method for obtaining transgenic plants showing a modified fructan pattern |
| 02/15/2000 | US6025541 Isolated non-coding nucleotide sequences useful as promoters for heterologous gene expression in plants |
| 02/15/2000 | US6025540 Transgenic non-human mammal comprising a dna sequence encoding human extracellular superoxide dismutase (human ec-sod) or a variant thereof which is expressed in the milk |
| 02/15/2000 | US6025485 Methods and compositions for peptide libraries displayed on light-emitting scaffolds |
| 02/15/2000 | US6025484 Protein D--an IgD-binding protein ofhaemophilus influenzae |
| 02/15/2000 | US6025477 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/15/2000 | US6025476 Method of detecting fibrinogen; diagnostic methods for determining information associated with atherogenesis and/or thrombogenesis, as well as for determining information associated with pregnancy status or outcome |
| 02/15/2000 | US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 02/15/2000 | US6025470 Provoke proliferation of cytolytic t cells |
| 02/15/2000 | US6025469 Murine UCP3 polypeptides |
| 02/15/2000 | US6025340 Surface expression of enzyme in gene directed prodrug therapy |
| 02/15/2000 | US6025339 Oligo is antisense to the initiation codon, the coding region or the 5' and 3' intronexon junctions of a gene encoding the adenosine a.sub.1 receptor or antisense to an adenosine a.sub.1 receptor mrna; and |
| 02/15/2000 | US6025204 Diagnostic method for detection of placental-derived prostate growth factors |
| 02/15/2000 | US6025197 Secreted salivary zsig32 polypeptides |
| 02/15/2000 | US6025196 Chimeric proteins comprising liver enriched transcription factors and nucleic acids encoding the same |
| 02/15/2000 | US6025188 Degrading a mycotoxin having a tricabyllic ester by contacting with an esterase enzyme; for treating grain, silage, food crops and animal feed |
| 02/15/2000 | US6025182 Method for producing a virus from an african green monkey kidney cell line |
| 02/15/2000 | US6025180 Asp1 |
| 02/15/2000 | US6025179 Method for cloning and producing the SnaBI restriction endonuclease and purification of the recombinant SnaBI restriction endonuclease |
| 02/15/2000 | US6025159 Nucleotide sequence from trigonopsis variabilis; for increased expression of heterologous genes in host systems by replacing promoter of selectable marker, leading to amplification of the plasmid |
| 02/15/2000 | US6025155 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 02/15/2000 | US6025148 Specifically reactive with the alpha e subunit; for diagnostic information relating to atherogenesis and/or thrombogenesis and pregnancy status or outcome |
| 02/15/2000 | US6025144 Immunoassay test kit for measuring bone resorption |
| 02/15/2000 | US6025143 Purified monoclonal or polyclonal antibody against a peptide having specific amino acid sequence from a gene controlled by andogens and isolated from submaxillary gland of the rat; for diagnosis, detection and therapeutics |
| 02/15/2000 | US6024984 Composition containing an extract from muirapuama root and plant worm extract |
| 02/15/2000 | US6024955 Peptide with amino acid sequences |
| 02/15/2000 | US6024953 Prevention of rabies in mammals, administering a hybrid vaccine |
| 02/15/2000 | US6024936 Antibody-based method of localizing activated thrombin receptors |
| 02/15/2000 | CA2223460C Induction of male sterility in plants by expression of high levels of avidin |
| 02/15/2000 | CA2093667C Mouse monoclonal antibodies and uses thereof |
| 02/15/2000 | CA2015994C Human lactoferrin cdna sequence |
| 02/15/2000 | CA2004478C Monoclonal antibodies to feline-t-lymphotropic lentivirus |
| 02/12/2000 | CA2248989A1 Novel compounds |
| 02/10/2000 | WO2000007018A2 Three-hybrid screening method for ligand-protein interactions |
| 02/10/2000 | WO2000006772A1 Mutations in and genomic structure of herg - a long qt syndrome gene |
| 02/10/2000 | WO2000006759A2 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 02/10/2000 | WO2000006758A1 Self-deleting vectors for cancer therapy |
| 02/10/2000 | WO2000006747A2 Enzymes for biopolymer production |
| 02/10/2000 | WO2000006744A1 Granulocytic ehrlichia genes and uses thereof |
| 02/10/2000 | WO2000006743A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006742A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006741A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006740A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006739A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006736A2 Nucleic acids and proteins from group b streptococcus |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006729A1 Kdel receptor inhibitors |
| 02/10/2000 | WO2000006726A2 Delta-related polypeptides |
| 02/10/2000 | WO2000006722A1 Eukaryotic cell-based gene interaction cloning |
| 02/10/2000 | WO2000006719A1 Nucleic acids encoding proteins involved in sensory transduction |
| 02/10/2000 | WO2000006717A2 Improved transformation efficiency in phage display through modification of a coat protein |
| 02/10/2000 | WO2000006713A2 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 02/10/2000 | WO2000006712A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 02/10/2000 | WO2000006709A1 Human protein kinase h2lau20 |
| 02/10/2000 | WO2000006705A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 02/10/2000 | WO2000006704A2 Hematopoietic cell composition for use in transplantation |
| 02/10/2000 | WO2000006703A2 Inhibition of graft versus host disease |
| 02/10/2000 | WO2000006702A1 Cancer cells from body fluids containing cells, isolation thereof and agents containing the same |
| 02/10/2000 | WO2000006701A1 Improvement of cardiac function by mesenchymal stem cell transplantation |
| 02/10/2000 | WO2000006700A1 Production and use of dopaminergic cells to treat dopaminergic deficiencies |
| 02/10/2000 | WO2000006698A1 98 human secreted proteins |
| 02/10/2000 | WO2000006605A2 Heterominibodies |
| 02/10/2000 | WO2000006601A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | WO2000006600A1 Human mink gene mutations associated with arrhythmia |
| 02/10/2000 | WO2000006598A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 02/10/2000 | WO2000006593A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 02/10/2000 | WO2000006592A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 02/10/2000 | WO2000006589A1 Prostate derived ets factor |
| 02/10/2000 | WO2000006205A1 Regulated expression of recombinant proteins using rna viruses |
| 02/10/2000 | WO2000006204A2 Genetically engineered cells and tissues |
| 02/10/2000 | WO2000006199A1 Kvlqt1 - a long qt syndrome gene |
| 02/10/2000 | WO2000006195A1 Targeting pharmaceutical agents to injured tissues |
| 02/10/2000 | WO2000006187A2 Modulation of apoptosis |
| 02/10/2000 | WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT |
| 02/10/2000 | WO2000006178A1 EX VIVO TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
| 02/10/2000 | WO2000006087A2 Uncoupling protein-2(hcp2): compositions and methods of use |
| 02/10/2000 | WO2000000510A8 Growth factor modulators |
| 02/10/2000 | WO1999064566A8 In vitro maintenance of hematopoietic stem cells |
| 02/10/2000 | WO1999060024A9 Methods for amyloid removal using anti-amyloid antibodies |
| 02/10/2000 | WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/10/2000 | WO1999055837A3 Improvements in or relating to separation processes |
| 02/10/2000 | WO1999053038A3 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| 02/10/2000 | WO1999049045A3 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 02/10/2000 | WO1999049039A3 GFRα3 AND ITS USES |
| 02/10/2000 | WO1999045126A3 Enhanced prodrug activation |
| 02/10/2000 | WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/10/2000 | DE19835368C1 Verfahren zur Herstellung einer Knorpelzellsuspension A process for the preparation of a cartilage cell suspension |
| 02/10/2000 | CA2776054A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 02/10/2000 | CA2356882A1 Graft versus host disease |
| 02/10/2000 | CA2340855A1 Granulocytic ehrlichia genes and uses thereof |
| 02/10/2000 | CA2339301A1 Hdpbo81 nucleic acids and polypeptides |
| 02/10/2000 | CA2339096A1 Modulation of apoptosis |
| 02/10/2000 | CA2338773A1 Ex vivo treatment of allogeneic and xenogeneic t-cells with gp39 antagonists |
| 02/10/2000 | CA2338643A1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 02/10/2000 | CA2338247A1 General screening method for ligand-protein interactions |
| 02/10/2000 | CA2338019A1 Prostate derived ets factor |
| 02/10/2000 | CA2337692A1 Kdel receptor inhibitors |